Gains and Losses of HLA Class II (DR) and CD4 in Atypical Hyperplasia, Carcinoma in situ and Infiltrating Ductal Carcinoma of the Breast

Autor: Seliniotakis E, Panagiotis Tsikouras, A. Tsalkidis, Papadopoulos N, Lambropoulou M, Limberis, Venizelos I, T. Jivannakis, Tamiolakisl D

Publikováno v: Acta Medica, Vol 47, Iss 4, Pp 257-262 (2004)

Aim: Breast cancer is a frequent cause of death among women with gynaecologic malignancies despite the introduction of combination chemotherapy. There is therefore a need for new therapeutic strategies for patients with breast cancer, such as cellula

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d16429d9d265dadee0ce093952ab894
https://doi.org/10.14712/18059694.2018.101

Spatially-resolved quantification of proteins in triple negative breast cancers reveals differences in the immune microenvironment associated with prognosis.

Autor: Stewart RL; Department of Pathology and Laboratory Medicine, University of Kentucky College of Medicine, Lexington, KY, USA., Matynia AP; Department of Pathology, ARUP Laboratories, University of Utah Medical Center, University of Utah, Salt Lake City, UT, USA., Factor RE; Department of Pathology, ARUP Laboratories, University of Utah Medical Center, University of Utah, Salt Lake City, UT, USA., Varley KE; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA. kt.varley@hci.utah.edu.

Publikováno v: Scientific reports [Sci Rep] 2020 Apr 20; Vol. 10 (1), pp. 6598. Date of Electronic Publication: 2020 Apr 20.